Document is current
Any future updates will be listed below
-
Authors
Lagomarsino, Valentina N. https://orcid.org/0000-0003-3195-1899
Robinson, Ariel
Mitchell, Perry E.
Jiang, Mira
Hutchinson, Lauren E. https://orcid.org/0009-0008-1712-7186
Sekela, Josh John
Caron, Patrick
Gehris, McKenzie K. https://orcid.org/0000-0002-1995-1442
Navas, Kathleen I.
Duarte-Silva, Murillo
Netherland, Michael Jr.
Hasan, Nur A.
Guillemette, Chantal https://orcid.org/0000-0002-1113-1212
Redinbo, Matthew R. https://orcid.org/0000-0003-0814-5346
Rao, Meenakshi https://orcid.org/0000-0002-8194-9204
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK130836)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK135707)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R03DK125636)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R01GM135218)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM152079)
- License Information
-
More Information
Article History
Received: 2 January 2026
Accepted: 27 April 2026
First Online: 2 June 2026
Competing interests
: M.R. received research support from Takeda Pharmaceuticals and collaborates with Fzata on unrelated studies. M.R.R. has received research support from Merck and Eli Lilly for unrelated studies, and is a founder of Symberix. M.N.J. and N.A.H. are current employees of Arius Bioscience. The other authors declare no competing interests.
